Education
About Us
Working with TipRanks
Follow Us
Steris plc (STE)
NYSE:STE
STE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$200.98 - $248.24
Previous CloseN/A
Volume53.54K
Average Volume (3M)554.01K
Market Cap
$22.11B
Enterprise Value$22.52B
Total Cash (Recent Filing)$214.97M
Total Debt (Recent Filing)$210.00M
Price to Earnings (P/E)47.7
Beta0.44
Next Earnings
May 14, 2025EPS Estimate
2.6Last Dividend Ex-Date
Feb 20, 2025Dividend Yield0.99%
Share Statistics
EPS (TTM)4.71
Shares Outstanding98,250,786
10 Day Avg. Volume376,509
30 Day Avg. Volume554,014
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.09
Price to Cash Flow (P/CF)16.30
P/FCF Ratio29.42
Enterprise Value/Market Cap1.02
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.15
Enterprise Value/Ebitda18.35
Forecast
1Y Price Target
$265.00Price Target Upside17.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Steris News
PremiumCompany Announcements
STERIS Reports Strong Q3 Results with Revenue Growth
PremiumCompany Announcements
STERIS Earnings Call Highlights Mixed Sentiment and Growth
---
Bulls Say, Bears Say
Bulls Say
Market ConfidenceThe Market Outperform rating is reiterated for STERIS, reflecting confidence in the company's future performance.
Revenue GrowthHealthcare segment revenue increased by 7% year-over-year, driven by growth in consumable and service revenue.
Shareholder ValueCompletion of $100 million in share repurchases and debt reduction efforts demonstrate a commitment to enhancing shareholder value and improving financial stability.
Bears Say
Foreign Exchange ImpactManagement adjusted guidance for FY25, reducing revenue growth expectations due to unfavorable foreign exchange rates.
Legal ExpensesOperating margin was down 10 bps Y/Y and below consensus as STE faced increased legal expenses related to its ongoing ethylene oxide (EO) trial.
Order BacklogIssues related to capital equipment orders and backlog are impacting the company's performance.
---
Ownership Overview
0.31% Insiders
28.04% Mutual Funds
0.74% Other Institutional Investors
45.44% Public Companies and
Individual Investors
STE FAQ
What was Steris plc’s price range in the past 12 months?
Steris plc lowest stock price was $200.98 and its highest was $248.24 in the past 12 months.
What is Steris plc’s market cap?
Steris plc’s market cap is $22.11B.
When is Steris plc’s upcoming earnings report date?
Steris plc’s upcoming earnings report date is May 14, 2025 which is in 15 days.
How were Steris plc’s earnings last quarter?
Steris plc released its earnings results on Feb 05, 2025. The company reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.321 by -$0.001.
Is Steris plc overvalued?
According to Wall Street analysts Steris plc’s price is currently Undervalued.
Does Steris plc pay dividends?
Steris plc pays a Quarterly dividend of $2.226 which represents an annual dividend yield of 0.99%. See more information on Steris plc dividends here
What is Steris plc’s EPS estimate?
Steris plc’s EPS estimate is 2.6.
How many shares outstanding does Steris plc have?
Steris plc has 98,250,786 shares outstanding.
What happened to Steris plc’s price movement after its last earnings report?
Steris plc reported an EPS of $2.32 in its last earnings report, missing expectations of $2.321. Following the earnings report the stock price went up 2.088%.
Which hedge fund is a major shareholder of Steris plc?
Currently, no hedge funds are holding shares in STE
---
Steris Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$265.00 (17.78% Upside)
$265.00 (17.78% Upside)
Blogger Sentiment
Bullish
STE Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 369.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $365.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
12.75%
12-Months-Change
Fundamentals
Return on Equity
9.61%
Trailing 12-Months
Asset Growth
-12.48%
Trailing 12-Months
Company Description
Steris plc
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
---
STE Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed view, with strong revenue growth and improved gross margins balanced by challenges in EBIT margin and segment-specific revenue declines, particularly in healthcare capital equipment and life sciences. Positive trends in free cash flow and the AST segment's growth were countered by ongoing litigation expenses and unfavorable currency impacts.Read More>---
STE Revenue Breakdown
73.00% U.S.
25.39% Other locations
1.61% Ireland
---
STE Stock 12 Month Forecast
Average Price Target
$265.00
▲(17.78% Upside)
Technical Analysis
---